Iverson Shawn M, Spierer Oriel, Papachristou George C, Feuer William J, Shi Wei, Greenfield David S, O'Brien Terrence P
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens, Florida, USA.
Br J Ophthalmol. 2015 Nov;99(11):1477-82. doi: 10.1136/bjophthalmol-2014-306547. Epub 2015 Apr 30.
To compare corneal graft survival rate after primary Descemet's stripping endothelial keratoplasty (DSEK) and primary penetrating keratoplasty (PK) in patients with prior trabeculectomy or medically managed glaucoma.
A retrospective chart review was conducted on consecutive patients who underwent DSEK or PK. Inclusion criteria consisted of eyes with a diagnosis of glaucoma prior to corneal transplantation and ≥ 6 months of follow-up. Graft failure was defined as an oedematous cornea with failure to maintain deturgescence lasting beyond a period of 1 month of intense steroid therapy or vascularisation and scarring resulting in irreversible loss of central graft clarity. Corneal graft survival was calculated using Kaplan-Meier survival analysis. Patients were divided into four groups: trabeculectomy-DSEK, trabeculectomy-PK, medical-DSEK or medical-PK.
Fifty eyes (30 DSEK, 20 PK) of 50 patients (mean age 77 ± 10 years) met the enrollment criteria. Mean follow-up was 17.4 ± 14.2 months. A significantly higher proportion of the DSEK grafts (50%) compared with PK grafts (10%) failed at last follow-up (p = 0.005). Kaplan-Meier analysis identified a significant difference between the groups with respect to time to graft failure (p = 0.006). Patients with trabeculectomy who underwent DSEK had earlier graft failures than all other groups (p ≤ 0.035), but there were no differences between the medical-DSEK, medical-PK and trabeculectomy-PK groups (all p > 0.35).
Eyes with prior glaucoma showed higher rates of DSEK graft failure compared with PK. Patients with prior trabeculectomy demonstrated higher and earlier corneal graft failure rates with DSEK than with PK.
比较原发性后弹力层剥除内皮角膜移植术(DSEK)和原发性穿透性角膜移植术(PK)在既往接受小梁切除术或药物治疗的青光眼患者中的角膜移植存活率。
对连续接受DSEK或PK的患者进行回顾性病历审查。纳入标准包括角膜移植术前诊断为青光眼且随访时间≥6个月的眼睛。移植失败定义为角膜水肿,在强化类固醇治疗1个月后仍未能维持消肿,或出现血管化和瘢痕形成,导致中央移植片清晰度不可逆丧失。使用Kaplan-Meier生存分析计算角膜移植存活率。患者分为四组:小梁切除术-DSEK组、小梁切除术-PK组、药物治疗-DSEK组或药物治疗-PK组。
50例患者(平均年龄77±10岁)的50只眼睛(30只DSEK,20只PK)符合纳入标准。平均随访时间为17.4±14.2个月。在最后一次随访时,DSEK移植片失败的比例(50%)显著高于PK移植片(10%)(p = 0.005)。Kaplan-Meier分析显示,各组在移植失败时间方面存在显著差异(p = 0.006)。接受DSEK的小梁切除术患者的移植失败时间早于所有其他组(p≤0.035),但药物治疗-DSEK组、药物治疗-PK组和小梁切除术-PK组之间无差异(所有p>0.35)。
与PK相比,既往患有青光眼的眼睛DSEK移植失败率更高。既往接受小梁切除术的患者,DSEK的角膜移植失败率高于PK,且失败时间更早。